Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nicotinamide adenine dinucleotide phosphate (NADP) is an essential coenzyme composed of a nicotinamide ring linked to an adenine nucleotide with an additional phosphate group. It serves as a key redox carrier in anabolic metabolic reactions, most notably in photosynthesis and biosynthesis, shuttling electrons and hydrogen ions in cells. NADP exists in two interconvertible forms, the oxidized NADP+ and the reduced NADPH. Its balanced redox function is crucial for the synthesis of fatty acids and nucleic acids, cellular energy production, protection against oxidative stress, and maintenance of metabolic homeostasis across all domains of life
N/A for direct drug targeting. Drugs acting on NADP-dependent enzymes typically inhibit or modulate the enzyme's ability to utilize NADP/NADPH for redox reactions
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nicotinamide adenine dinucleotide phosphate (NADP).